What the research found
Researchers tracked glucose patterns in over 1,000 adults without diabetes using 10-day continuous glucose monitors, then correlated the data with 13 different health domains including heart function, blood pressure, kidney markers, and cognitive performance. They identified four distinct glucose behaviour clusters—ranging from consistently healthy to persistently elevated—rather than a simple spectrum.
The headline finding: about 1 in 5 statistical associations between glucose metrics and health measures held up after correcting for multiple comparisons. Elevated average glucose and large glucose swings showed stronger links to health markers than glucose variability alone. Cognitive performance proved surprisingly sensitive; greater hyperglycemia and wider glucose excursions correlated with slower processing speed and lower language scores, though the effect sizes were modest.
Critically, A1C—the standard 3-month glucose average—misclassified many participants. Nearly 60% of people with "normal" A1C still fell into unfavorable glucose phenotypes on the monitor, while nearly 1 in 5 people flagged as prediabetic showed more benign patterns. The subgroup with sustained hyperglycemia had the worst cardiometabolic profile overall.
Why it matters for you
If you're tracking metabolic health through fasted glucose, A1C, and lipids, this suggests those snapshots miss meaningful variation. Someone with a "normal" A1C could still have chronically elevated glucose or large postprandial spikes—patterns now linked to measurable organ stress and cognitive dulling. A 10-day CGM window appears to capture heterogeneity that standard labs don't.
For protocol design: the cognitive associations are intriguing if preliminary. If sustained glucose elevation impairs processing speed and language fluency, optimising glucose stability might matter not just for diabetes prevention but for mental performance—something many users already prioritize via sleep, training intensity, and supplement timing.
The phenotyping approach also hints that one-size-fits-all targets may miss the point. Your ideal glucose range and acceptable variability might differ from someone else's, depending on your underlying pattern. This reinforces why monitoring—not just testing—adds practical value.
Caveats
- Cross-sectional design: associations don't establish causation; poor cognitive performance might drive poor glucose control, not vice versa.
- Modest effect sizes: the cognitive correlations were small (rho ~−0.10 to −0.14); clinical significance unclear.
- No diabetes diagnoses: findings don't directly apply to people with established T2D or those on glucose-lowering drugs.
- Single 10-day snapshot: one monitoring window may not reflect long-term phenotype stability or seasonal variation.
- Unmeasured confounders: adjustment for age, sex, and BMI is basic; diet quality, physical activity, and sleep weren't controlled.